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The  so  called  "Gordon  agent"  (1)  is  present  in  the  lymph  nodes  of 
Hodgkin's disease, as well as in other normal and pathologic tissues of both 
man and animals.  Intracerebral inoculation of this  agent into susceptible 
hosts  produces  clinical  disease  and  distinctive pathologic  damage,  fuUy 
considered in a  previous paper  (2),  and characterized chiefly by selective 
necrosis of Purkinje ceils. 
The nature of this pathogenic agent has received considerable attention in the litera- 
ture.  That it is not restricted to Hodgkin's disease tissues was soon apparent.  Gordon 
(3)  obtained  the  characteristic  clinical reaction  from injection into rabbits  of human 
pus.  Friedemann  and  Elkeles  (4)  and  Friedemann  (5)  demonstrated  the  agent  in 
normal human bone marrow, spleen, and the leucocytic cream of normal human blood, 
as well as from marrow from "acute leukemia."  Although Van Rooyen (6)  could not 
demonstrate  the  importance  of  eosinophilia,  Turner,  Jackson,  and  Parker  (7),  and 
McNaught (8) showed convincingly that the potency of the test material derived from 
human beings was roughly proportional to the number of eosinophils in the inoculum. 
That the agent is not restricted to the primate eosinophil was proved by Edward  (9), 
who produced the characteristic result with mouse spleen and with chicken spleen and 
marrow.  The potency of mouse spleen has been confirmed by the present author.  The 
relationship of mouse and chicken eosinophils to those of primates is not unequivocal. 
What cell type in the lower animals gives rise to the agent responsible for the phenome- 
non cannot at present be decided.  It has been shown by MacKenzie and Van Rooyen 
(10)  that the pathogenic agent is not identical with known proteolytic enzymes derived 
from leucocytes. 
A few of the elementary properties of the Gordon agent have been described in the 
literature.  It is inactivated by a  temperature  of 75-80°C. acting for half an hour (1, 
11).  Uhlenhuth and Wurm (11) found activity retained at a pH of 3.45, although Van 
Rooyen earlier observed inactivation below pH 6.8.  The agent is readily adsorbed by 
kaolin (11)  and kieselguhr (12).  It is resistant to extreme cold (12) and desiccation (1) 
and may be kept  desiccated or in glycerin for long periods of time.  In addition  the 
agent  resists  x-ray  (12),  weak phenol,  and formalin,  as well as ether  and  chloroform 
(1, 11).  It is destroyed by antiformin acting for 30, but not for 15 minutes.  Successful 
filtration can be accomplished with difficulty only if the filter is properly lined and atten- 
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tion paid to pH (12).  Edward (13)  attempted ultracentrifugation,  and could find no 
evidence of sedimentation.  Indeed,  after  high  speed  centrifugation  the  supernatant 
fluid was sometimes more active than control  uncentrifuged  material.  He suggested 
either a lipoid nature of the agent or adsorption to lipoid particles. 
All authors  are now agreed that  the agent is not transmissible  in series  from one 
affected animal  to normal animals.  The active agent,  injected intracerebrally  into a 
susceptible host, exerts its effect but cannot be recovered from the brain.  The sugges- 
tion has been advanced in a previous paper (2)  that the action may be an interference 
with  cell  respiration. 
It has been shown previously (14)  that the action of the agent is exerted on hetero- 
logous species  only.  Monkey bone marrow, potent against guinea pigs and rabbits, is 
harmless against monkeys.  Recently Edward (9) has shown that although chickens are 
susceptible to the active agent, and although chicken spleen contains the agent, injec- 
tion of chicken tissue into chicks is without pathologic effect. 
No  unequivocal  evidence  of  immunological  reactions  has  been  brought  forward 
in  regard  to  the  Gordon  agent.  This  aspect  has  been  most recently  considered  by 
Edward (13). 
The present  communication reports further studies  on the nature  of the 
encephalopathic  agent in monkey bone marrow. 
Material and Methods 
In the present experiments the active agent under investigation was derived exclu- 
sively from monkey bone marrow.  Most of the monkeys were supplied by friends and 
colleagues,  and  had  been  used  in  virus  and  immunological  investigations.  Several 
others were purchased from dealers expressly for the present study.  No difference could 
be detected between the used and unused animals.  Monkeys suffering from tubercu- 
losis,  and those dead of poliomyelitis, furnished extracts as potent as normal controls. 
There was considerable variation in the potency of marrow of different animals, but this 
variation could not be correlated with any factor of previous exposure to experimental 
conditions.  Unused monkeys varied similarly. 
Preparation of Extract.--The bone marrow was prepared and treated in the following 
manner.  The long bones of the extremities were removed, the epiphyses sawed off, and 
the marrow was pushed out with an applicator.  4 to 6 gm. of marrow were obtained 
from a single animal.  The bone marrow was then placed in about 15 volumes of acetone 
where it remained several hours to several days.  The acetone was filtered off, and the 
residue washed with absolute alcohol, followed by ether, and then allowed to dry on the 
filter paper for several hours.  The dried marrow weighed approximately one-fifth of 
the initial amount.  A small proportion of this difference represents actual loss of solid 
material,  but most of it is accounted for by removal of lipoids and water.  The dried 
extract was mixed with about  15 volumes of 50 per cent glycerin.  An exact measure 
was of no significance, because of normal variations in potency. 
The material was kept in glycerin in a refrigerator.  To prepare extract for injection, 
the glycerin was cleared of the solid material first by filtering through cheesecloth, and 
then by centrifugation.  An aliquot of the glycerin was mixed with about 5 volumes of 
a mixture containing 3 parts of absolute alcohol and 1 part of ether.  The copious pre- 
cipitate  was collected by centrifugation and,  after the absolute alcohol-ether mixture L~.S~R  S.  Kn~G  605 
had been drained off, was suspended in buffered saline of a pH of 7.4.  The amount of 
saline added depended on the potency of the material determined by preliminary tests. 
As a rule of thumb, the precipitate from 1 ml. of glycerin was taken up in 1 ml. of saline, 
but the proportions were readily varied if the bone marrow was especially strong or 
especially weak. 
Saline suspensions  of  bone  marrow,  without  any  previous  extraction,  are potent. 
But use of a  saline suspension is complicated by fatty substances in the inoculum and 
does not lend itself to storage of the material.  Consequently in all experiments herein 
reported the inoculum was prepared according to the method given above. 
Quantitative Estimations.--The  active agent can be detected only by biological test. 
The quantity of precipitate thrown down from the glycerin by the action of the absolute 
alcohol-ether mixture furnishes no indication of the strength of the final preparation. 
For measuring the activity of a given sample, intracerebral inoculation into guinea pigs 
was employed.  The animals averaged between 250 and 300 gm. in weight, a few being 
lighter, a few heavier.  The dosage was 0.20 cc. 
Injection of potent material resulted in death, or in symptoms with partial or complete 
recovery.  As pointed out in a previous paper (2) the effect of the agent may be detected 
histologically as well as by the clinical syndrome already described.  The histological 
picture, in reference to the damage to the Purkinje cells of the cerebellum, was abso- 
lutely constant and invariable, and much more reliable than clinical observation of the 
animal.  A  combination of both clinical and  pathological observation, together with 
dilutions of the inoculum, furnished a  rough quantitative measure for the procedures 
reported below. 
The  clinical severity was graded from 0  to  +  +  +  +.  Zero signified that  at  the 
termination of the experiment the guinea pig was free of symptoms and indistinguishable 
from normal.  A  mild degree of clinical disturbance may have been present but had 
totally regressed.  In  such  instances  histological examination revealed characteristic 
damage.  A clinical designation of +  +  +  +  meant that the animal was unable to rise. 
A mark of +  +  +  meant the animal was prostrated at times but could still regain its feet 
on occasion.  Marks  of  +  or  +  +  indicated ataxia and incoordination of greater or 
less degree, but without prostration.  When death occurred before the end of the experi- 
ment it was so indicated. 
For histological grading, the cerebellums of the experimental guinea pigs were sec- 
tioned in the sagittal plane, and midsagittal sections stained with toluidine blue.  As 
already described, the essential pathological process--the destruction of the Purkinje 
cells--first takes place around the periphery.  A mark +  indicated that a portion only 
of the peripheral Purkinje cells was destroyed, but the damage was definite, charac- 
teristic, and unmistakable; +  +, that the destruction extended around almost the entire 
periphery;  +++,  that  the  more  deeply placed  folia were  markedly affected;  and 
+  +  +  +, that the destructive process was maximal in intensity over the entire section 
(Fig. 2). 
In case of a difference between clinical and pathological observation, the latter must 
be the final criterion.  Clinical disturbance, when mild, may be non-specific.  In such 
instances a histologically normal cerebellum required a dismissal of slight symptoms as 
unrelated to the disease picture.  On the other hand, symptoms might be transient and 
questionable, yet if unmistakable pathologic disturbance was present the animal was 
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OBSERVATIONS 
Susceptible Hosts.--Although  all  the experimental work detailed below 
was performed with guinea pigs,  other animals are susceptible.  Rabbits 
were first used by Gordon and by other investigators.  Recently Edward 
(9)  has  shown that  chickens may be affected by the agent derived from 
human bone marrow.  This has been confirmed.  Young chicks were found 
to respond to monkey bone marrow extracts in a way generally similar to 
guinea pigs,  with identical pathologic changes in  the cerebellum and the 
blood vessels at the base of the brain.  However, chicks reacted much less 
constantly and less sensitively than guinea pigs.  Clinical symptoms were 
also much more difficult to determine in the fowl.  For routine use guinea 
pigs were superior to either rabbits or chicks. 
Effective Routes of Inoculation.--The  active agent is  effective when in- 
jected directly into the brain substance or into the cisterna magna without 
injury to brain tissue.  Subcutaneous and intraperitoneal inoculations were 
without pathologic  effect, even if  the brain  was  simultaneously trauma- 
tized.  Injection into  the  eyeball, whereby the  agent is  in  contact with 
nerve cells although not with cerebrospinal fluid, did not produce the disease 
picture. 
Stability  of the Agent.--Although  systematic experiments were not per- 
formed,  certain  incidental observations  may be  recorded.  The  monkey 
bone marrow preserved in glycerin in the refrigerator remained potent for 
at  least  7  months,  in  excellent agreement with  the  data  on  Hodgkin's 
disease  tissue.  The  final  buffered  saline  suspension  of  material  pre- 
cipitated from glycerin remained active when kept at room temperature for 
17  days.  This corrects a  previous observation  (14)  that the final extract 
became inert on standing 24 to 48 hours.  Bone marrow kept in acetone in 
the refrigerator for 4 months was found to be fully active when the remain- 
ing stages of preparation of the extract were then performed. 
Solubility of the Agent at ptt 7.4.--When the precipitate from the glycerin 
is mixed with saline it is never completely dissolved.  In many experiments 
use of the entire resulting suspension was entirely satisfactory.  But fre- 
quently a  solution of the agent free from particulate matter was essential. 
It was necessary, therefore, to determine the relations between the amount 
of active agent in solution and in the whole suspension.  As will be shown 
subsequently the amount of agent in solution depends on the hydrogen ion 
concentration.  For  routine  use,  physiological  salt  solution  buffered  at 
pH 7.4 with phosphate buffers was employed. 
A suspension of bone marrow extract was made up in buffered saline and allowed to 
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to ~erve a~ a sample of whole suspension.  The remainder was centrifuged in a horizontal 
centrifuge for 1 hour at a speed of approximately 2000 g.P.~.  The supernatant fluid 
was then drawn off.  The whole suspension and the supernatant were diluted and in- 
jected into guinea pigs which were allowed  to live 6 days. 
The results are shown in Table I.  The whole suspension is very slightly 
more active than the supernatant fluid alone, but the difference is not great. 
The active agent is highly soluble at pH 7.4,  and  such a  solution  contains 
practically all of the agent present in any given sample. 
TABLE  I 
Comparison of Whole Suspension and Supernatant Fluid (pH 7.4) after 
Horizontal Centrifugation 
Inoculum 
Whole suspension 
Supernatant  after  cen- 
trifugation 
Dilution 
1:12 
1:4 
1:1 
1:12 
1:4 
1:1 
Guinea pig No. 
9 
10 
11 
12 
Result 6 days after  inoculation 
Clinical 
4- 
+ 
++ 
++ 
+++ 
++++ 
4- 
4- 
+ 
++ 
++++ 
+++ 
Pathological 
++ 
++ 
++ 
++ 
+++ 
++÷÷ 
4- 
+ 
++ 
++ 
+++ 
+++ 
Heat Inactivation.--The  thermal  inactivation  point  for the  active  agent 
contained in Hodgkin's disease tissue has been determined  by previous in- 
vestigators.  It was deemed of  interest to establish data in regard to mon- 
key bone marrow. 
A clear solution of bone marrow extract at pH 7.4 was obtained by centrifugation. 
Portions were heated in water baths at temperatures shown in Table II, and then inocu- 
lated into guinea pigs.  In cases where precipitate formed as a result of the heat treat- 
ment, the suspended precipitate was included  in the inoculum. 
The results of two  such  experiments are  shown  in Table II.  Although 
the  solutions  were initially  clear, heat  of  70°C.  or  over  resulted  in a  pre- 
cipitate  of  coagulated  protein,  minimal  but  yet  definite  at  70  °,  and  cor- 608 
respondingly more  at  higher  temperatures. 
60  ° or 65 ° did not result in precipitate. 
TABLE  II 
Inactivation of Active Principle by Heat 
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The  use  of  temperatures  of 
Inoculum heated 
Time  Temperature 
oC. 
15 rain.  80 
75 
70 
65 
6O 
Experiment 
Control, unheated 
20 min.  100 
90 
80 
7O 
Control, unheated 
Guinea pig No. 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
Results at end of experiment 
Clinical 
4-to+ 
0 
4- 
4- 
0 
4- 
Died, 9 days 
4- 
÷÷÷÷ 
Died, 9 days 
Died, 6 days 
Died, 6 days 
4- 
0to 4- 
4-  to+ 
4- 
0 
4- 
Died, 8 days 
Died, 8 days 
Pathological 
4- 
0 
0 
0 
÷ 
÷ 
÷÷÷ 
4- 
÷÷÷÷ 
+++ 
+÷÷ 
+÷÷+ 
0 
+ 
+++ 
+÷++ 
Experiment 1.  Surviving guinea pigs sacrificed after 12 days. 
Experiment 2.  Surviving  guinea pigs sacrificed after 10 days. 
At  60  °  there  is  apparently  no  diminution  in  potency,  but  potency  is 
reduced at 65 °, still further reduced at 70  °, and absent above that point. 
Guinea pig  1 in Table II showed very questionable changes.  Repetition, LESTER  S.  KING  609 
as shown in the table, indicated the lack of significance of this questionable 
instance.  The results, indicating retention of potency at 60  ° , with diminu- 
tion in the next 10 degree temperature range, and inertness above 70  ° , are 
in fairly close agreement with the results of Gordon (1) and Uhlenhuth and 
Wurm  (11)  with  Hodgkin's  disease  tissue.  The  inactivation  point  is 
slightly lower with the monkey bone marrow. 
A  further experiment was performed in which quantitative comparisons 
were made between material heated at 60  ° for an hour and unheated con- 
trols.  With dilutions of 1 : 10, 1 : 4, and 1 : 1 (undiluted) the heated samples 
proved to be slightly less active than unheated controls, but the difference 
was  not great. 
Solubility  of Agent at  Various Hydrogen Ion Concentrations.--In  all  the 
experiments  described  in  this  paper,  the  agent  was  precipitated  from 
glycerin  by  the  action  of  absolute  alcohol  and  ether.  This  precipitate, 
when injected as a whole suspension, was active over a wide range of hydro- 
gen ion  concentrations.  Preliminary experiments showed  that  when  this 
precipitate was mixed with saline at pH 2.8, 3.2, and 4.7, allowed to stand at 
these  acidities  overnight,  neutralized,  and  then  injected  as  a  whole  sus- 
pension into guinea pigs, the animals contracted the typical disease picture, 
both clinically and pathologically. 
It is thus apparent  that  the agent is not inactivated by relatively high 
hydrogen ion  concentrations.  The  question  remains,  however,  regarding 
the  solubility of the  agent  at  these  different concentrations.  The active 
principle  is  almost  entirely soluble  at  pH  7.4  (Table I).  It remained  to 
determine the relative solubilities at lower pH. 
To each of 5 centrifuge tubes containing 10 cc. of absolute alcohol-ether mixture, 2 
cc.  of  agent-containing glycerin were  added.  The  resulting  precipitates  were  cen- 
trifuged down, and the supernatant liquid was drained off.  Buffer solutions were added 
to each tube to produce a final pH of 2.0, 3.0, 4.2, 5.0, and 6.8.  The first two buffers 
were HCl-glycine, the second  two, acetic acid-acetate, and the last, phosphate.  The 
final result was determined by indicators, and is approximate only.  The tubes were 
allowed to stand overnight, about 21 hours, and then centrifuged at about 2500 Ra,.~. 
for an hour.  Perfectly clear supernatant fluids resulted.  From each sample  1 cc. was 
removed into small test tubes, a  drop of phenol red added, and the pH adjusted to 
approximately 7.2.  Since different amounts of alkali were added to different tubes, all 
were brought to a constant volume by the addition of appropriate amounts of distilled 
water.  From each tube one portion was saved for use undiluted (1 : 1); a second portion 
was diluted 1:6.  Intracerebral injections into guinea pigs were then performed.  Some 
denaturation of protein occurred in the tubes of pH 2.0, and much less at 'pH 3.0.  This 
was shown by the formation of a precipitate as the acid solution was neutralized.  In 
such instances  the entire resulting suspension  was injected. 610  ENCEPHALOPATHIC  AGENT  IN  PRIMATE  BONE  MARROW 
In Table III the results of this experiment are set forth.  The results are 
fairly clean cut.  At pH 6.8  the active agent shows a high degree of solu- 
bility, while at pH 2.0 and 3.0 there is also high solubility.  At intermediate 
TABLE  III 
Solubility of Agent at Different Hydrogen Ion Concentrations 
pH 
2.0 
3.0 
4.2 
5.0 
6.8 
Results, 6 days after inoculation 
Dilution 
1:6 
1:1 
1:6 
1:1 
1:6 
1:1 
1:6 
1:1 
1:6 
1:1 
Guinea pig No. 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Clinical 
+ 
+ 
Died, 3 days 
+++ 
+ 
+ 
+++ 
+++ 
.4_ 
0 
+ 
0 
++ 
0 
++ 
+++ 
Pathological 
++ 
++ 
+++* 
+++ 
+ 
++ 
++ 
+++ 
++ 
0 
++ 
+ 
+++ 
++++ 
All inocula adjusted to pH 7.2 and made up to equal volume before dilution. 
* Pathological evaluation difficult  because of postmortem changes. 
hydrogen ion concentrations the solubility is negligible, absent at 4.2, and 
very  slight  at  5.0.  These  results  indicate  a  point  of  minimal solubility 
of the agent at approximately pH 4.2. 
Digestion  by  Pepsin.--Evidence  on  the  possible  protein  nature  of  the 
agent might be furnished if the activity were destroyed by pepsin.  Of the 
various protein-splitting enzymes pepsin is well suited for this test.  The /ESTER S.  KING  611 
low pH required for its activity does not affect the agent under investiga- 
tion.  Furthermore, since the biological test requires intracerebral inocu- 
lation, it is necessary that the excess of enzyme be completely inactivated 
before injection.  With pepsin this is readily accomplished by simple neu- 
tralization of the inocuhm. 
A suspension of active bone marrow extract was made,  using 0.1 normal hydrochloric 
acid as the diluting fluid.  One portion was saved for control.  To the remainder, an 
excess of pepsin was added (1 rag. of purified crystalline pepsin, kindly furnished by Dr. 
Roger M. Herriott).  Both portions were allowed to stand at room temperature over- 
night.  In the morning both samples were neutralized with sodium hydroxide and in- 
jected into guinea pigs, 5 animals being used for each test. 
TABLE IV 
Effect of Pepsin on Active Agent 
Inocuhm 
Extract in 0.1 ~ HC1 plus pepsin 
Extract in 0.1 N HC1.  No pepsin 
(Control) 
Inocula neutralized before in 
N~.  = not examined. 
Result after  28  days 
Clinical 
o 
o 
-4- 
o 
o 
Guinea  pig  No. 
Died, 8 days 
+ 
Died, 11 days 
Died, 9 days 
10  ++++ 
Pathological 
NE 
+++ 
NE 
NE 
++++ 
ection. 
The data on this experiment are presented in Table  IV.  This experi- 
ment was allowed to run 28 days.  Of the control group 3 animals died after 
typical  clinical  signs.  The  remaining  2  survived  with  symptoms,  but 
showed marked  characteristic lesions  at  autopsy.  Guinea pig  7,  at  the 
termination  of  the  experiment,  showed  only  slight  residual  symptoms. 
Much more severe symptoms, present earlier, had partially regressed in the 
long period following inoculation.  The pathological injury, however, never 
regresses.  Of  the  group of  animals receiving the pepsin-treated extract, 
all  survived with no  clinical disturbance except for one  questionable in- 
stance  (No.  3)  and with no histological evidence of injury.  As has been 
repeatedly emphasized, questionable and very slight symptoms are of no 
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To rule out the possibility that this inactivation by pepsin was simple 
instantaneous  inhibition  rather  than  true  digestion  (15),  the  experiment 
was repeated with the following variations.  A clear solution of bone mar- 
row extract in 0.1 N HCI was treated with pepsin, and samples werewith- 
drawn  at  intervals  for  neutralization.  After neutralization  the  samples 
were all injected at the same time at the expiration of the last interval. 
As seen in Table V, the first sample, neutralized after a lapse of about 10 
seconds, remained active and is identical with the control, while subsequent 
samples were completely inactivated.  The conclusion may be drawn that 
the inactivation represents a  true digestion. 
TABLE  V 
Time Relations of Pepsin Inactivation 
Pepsin acting for 
10 sec. 
llhrs. 
12 hrs. 
Control (12 hrs.) 
Results after 7 days 
Clinical 
++++ 
Died, 6 days 
! Guinea pig No. 
+ 
Died, 6 days 
Pathological 
+++ 
+++ 
+++ 
* Died on 7th day of intercurrent disease. 
Ultracentrifugation.--The  only  experiments  recorded  in  the  literature 
concerning the possible  sedimentation of the active agent by high  speed 
centrifugation are those of Edward  (13).  He used human bone marrow 
or lymphadenomatous glands,  suspended in saline or 5 per cent glycerin, 
and cleared of particulate matter by low speed centrifugation and filtration. 
Portions of this material were centrifuged at 40,000 R.P.M., and the superna- 
tant was compared with uncentrifuged control solutions to test for possible 
diminution  of  activity.  The  fiter of  the  supernatant  after  ultracentri- 
fugation  was  generally  slightly  higher  than  the  uncentrifuged  control. 
Edward suggests that either an essential lipoid nature or an  adsorption  to 
lipoids may account for this result. 
Preliminary experiments with monkey bone marrow, prepared according 
to  the directions given in  Methods, did not confirm these findings.  The 
following description shows a more detailed experiment. LESTER  S.  KING  613 
An extract was prepared as usual from the glycerin mother-liquor by precipitation 
with absolute alcohol-ether.  The precipitate was taken up in saline at a pH of 7.4 and 
allowed to stand overnight.  The next morning the suspension  was spun in a horizontal 
centrifuge for 1 hour at about 2700 R.V.M. and the perfectly clear amber supernatant 
fluid removed.  5 cc. of this was placed in an air-driven centrifuge, which  was run at 
33,000 R.P.M. for 1½ hours.  A slight red pellet about the size of the heads of 2 common 
pins was formed.  The supernatant two-thirds was carefully removed and subjected to 
a second run of 1½ hours at 33,000 R.~.x(., and the uppermost third after the second run 
was removed for inoculation.  At the same time the bottom third remaining after the 
first run was utilized for comparison.  The pellet, presumably hemoglobin or a hemo- 
TABLE  VI 
Effect of Ultracentrifugation on Solution of Active Agen~ 
Inoculum 
Tppermost  third  after  two 
centrifugations 
~ottom third of first centrifu- 
gation 
Dilution 
1:12 
1:4 
1:1 
1:12 
1:4 
Guinea pig No. 
9 
10 
Result after 6 days 
++++ 
+++ 
++++ 
++++ 
1:1  11 
12 
Clini~l  Pa~ol~ 
o  ± 
o  0 
+  + 
++  ++ 
+++ 
+++ 
+  ++ 
+  ++ 
++  ++++ 
++  +++ 
++++ 
++++ 
globin complex, was redissolved before use.  The 2 samples were diluted and injected 
into guinea pigs. 
In this experiment out of a  given sample the uppermost third  after two 
high  speed  centrifugations  was  directly  compared  with  the  bottom  third 
after  the  first  centrifugation.  The  results,  given in  Table  VI,  show  that 
the uppermost third is slightly but definitely less active than the lowermost 
third.  This  indicates  a  slight  degree  of  sedimentation  of  the  agent,  but 
totally  insufficient  for purposes  of purification. 
The differences between these results and those reported by Edward are 
probably  to  be  explained  by  the  different  methods  of preparation  of  the 
material.  In  the  present  case,  the  preliminary  treatment  with  acetone, 614  ENCEPI:I.ALOPATHIC  AGENT  IN  PRIMATE  BONE  MARROW 
with the use of alcohol-insoluble precipitate to prepare  the final solution, 
got rid of most of the lipoids which apparently complicated the experiments 
of  Edward. 
Dialysis.--For possible purification of the agent it was necessary to de- 
termine whether it would be retained by cellophane or collodionmembranes. 
In one experiment a  solution of bone marrow extract was dialyzed for 22 
hours  in  a  rocking  dialyzer  against  running  distilled  water  through  a 
cellophane membrane.  Injection of  the  dialyzed material into  3  guinea 
pigs  resulted in  death,  with  characteristic symptoms, after  8,  9,  and  10 
days,  respectively.  At  the  same  time  control undialyzed solution killed 
3 guinea pigs in 8, 8, and 19 days.  Histologic examination was not done on 
these animals.  The results show no evidence of loss of activity through 
dialysis. 
A more detailed experiment was carried out as follows  :-- 
A perfectly clear solution of bone marrow extract at pH 7.4 was divided into two 
portions.  One portion was retained as control; the other, 5 cc., was placed inside a 
cellophane bag containing several glass beads.  The bag was immersed in 5 cc. of saline 
at the same pH, and allowed to stand in a closed test tube at room temperature for 3 
days, with agitation about once an hour during the day.  The dialysate (that is, the 
solution outside the bag) was saved, and the bag was then subjected to further dialysis 
in a rocking dialyzer, against running buffered saline of the same pH.  This  was con- 
tinued for 2 hours to remove  any further dialyzable  material.  Previous  tests had shown 
that with the rocking dialyzer used, haft-saturated ammonium sulfate was rendered 
negative to Nessler's reagent in less than this period.  2 hours' dialysis against running 
saline, supervening  on the previous 3 days, was deemed adequate to remove any dialyz- 
able material from within the bag.  The dialyzed solution as well as the undialyzed 
control was then diluted and injected into guinea pigs.  The dialysate was injected 
undiluted. 
In Table VII the results of this experiment are presented.  It is apparent 
that after 3  days of simple dialysis no evidence of passage  of the active 
agent through the membrane into the dialysate could be found.  Further- 
more, after additional dialysis against running saline, there was no diminu- 
tion of activity of the dialyzed material compared with undialyzed controls. 
The conclusion may be drawn that the active agent is non-dialyzable. 
Precipitation with Ammonium Sulfate.mSeveral experiments were carried 
out in which, to clear saline solutions of the active agent, calculated amounts 
of crystalline ammonium sulfate were added to produce varying degrees of 
saturation  with  this  salt  at  room  temperature.  The  precipitates  were 
collected and redissolved, and after dialysis, precipitate and  supernatant 
were separately injected into guinea pigs.  At 0.3 saturation, no precipitate 
occurred.  At 0.4 saturation, there was slight precipitate, which contained LESTER s.  ~Nc  615 
a  barely detectable trace  of activity.  The  supernatant  remained  active. 
At 0.8  saturation,  there  was copious precipitate,  which  was active, while 
the  supernatant  fluid showed no residual  activity.  At 0.5  saturation  the 
activity was quite equally divided between the  supernatant  and  the pre- 
cipitate.  Table VIII is an example of one of these experiments, with half- 
saturated ammonium sulfate.  Further work is required to determine more 
accurately  the  optimum  range  of percentage  saturation  with  ammonium 
TABLE  VII 
Effect of Dialysis on Active Agent 
Inoculum 
Dialyzed solution 
Dilution 
1:4 
1:1 
Guinea pig No. 
Results after 9 days 
Cli~cal  Pa~ological 
+  ++ 
+  ++ 
±  ++ 
+++  +÷+ 
++  +++ 
+++  +++ 
Dialysate 
Control solution, undialyzed 
1:1 
1:4 
1:I 
10 
11 
12 
0 
:t: 
0 
0 
+ 
+ 
13 
14 
15 
++ 
++ 
+++ 
0 
++ 
++ 
+++ 
+++ 
++ 
sulfate for the isolation of the active agent.  The range lies roughly between 
0.4 as the lower limit, and somewhat less than 0.8 as the upper. 
Immune Reactions.--Although  from  the  literature  no  unequivocal  evi- 
dence of immunity to the active agent is forthcoming, a preliminary experi- 
ment  gave  suggestive  results.  2  guinea  pigs  received  3  weekly subcu- 
taneous  injections  of extract  of  proved potency and  then  were tested by 
intracerebral  inoculation.  The  2  animals  showed  typical  symptoms,  but 
survived.  2  controls died.  This  experiment  was repeated  3  times,  with 
results shown in Table IX.  It can  be seen that Experiment 2 is suggestive, 
for  4  animals  which  received  the  subcutaneous  injections  survived  the 
intracerebral  inoculation,  while  the  controls  died.  However,  this  result 
was obtained on only one out of three  attempts.  As shown in the second 616  ENCEPHALOPATHIC  AGENT  IN  PRIMATE  BONE  MARROW 
TABLE  VIII 
Effect of Half-Saturations  witk Ammonium Sulfate (and Dialysis)  on Solution  of 
Active Agent 
Inocuium 
Supematant 
Sediment 
Dialyzed control 
Dilution 
1:4 
1:1 
1:4 
1:1 
1:4 
Guinea pig No. 
Results after 8 days 
Clinical 
++ 
++ 
1:1 
9 
10 
11 
12 
+ 
+ 
+ 
+ 
+++ 
+++ 
Pathological 
+ 
0 
+++ 
+++ 
++ 
+++ 
+ 
++ 
++++ 
++++ 
TABLE  IX 
Attempted  Production of Immunity by Subcutaneous Inoculation  of Agent 
Immunity  test 
Experiment  No.  I  N°' 
1  3 
2  4 
3  6 
of subcutaneous 
inoculations 
Injected guinea  pigs  Controls 
7, 7, 8, 10 
S, S, S, S 
7, 8, 9, 10, 11 
6, 7, 7, 9 
6, 6, 7, 7 
8, 8, 10, 10 
7, 7, 8, 10  --- guinea pigs died in 7, 7, 8, or 10 days, respectively. 
S  =  survived.  Killed 28 days after test inoculation. 
Condition of Survivors of Experiment 2 (above), Examined 4 Weeks  after Inoculation 
Guinea pig No.  Symptoms  Pathology 
i  +  +++ 
2  +  +++ 
3  ++  to +++  +++ 
4  +  to ++  ++++ 
part  of Table IX,  the survivors of Experiment  2  all  showed marked  brain 
damage, although  their clinical signs had regressed.  The subcutaneous  in- LESTER  S.  KING  617 
jections  did  not  prevent  the  severe  pathological  damage,  the  essential 
feature of the disease, which results from intracerebral inoculation.  Ex- 
tensive experience with guinea pigs has shown that the degree of cellular 
damage is the criterion of the effect of the agent; death or survival are of 
secondary importance.  Consequently these data are presented as negative 
results, in agreement with those of Edward (13), who worked with intraven- 
ously  injected  rabbits. 
COMMENT 
From the data presented above, it seems probable that the active agent 
is either a  protein or intimately associated with a  protein.  There is no 
evidence, either in these experiments or in the literature, which is incon- 
sistent with this viewpoint.  It would obviously  be desirable to attempt 
isolation and purification of the agent.  For such a purpose more abundant 
material than is furnished by monkeys is essential.  The spleen and lymph 
nodes of a  single active case of Hodgkin's disease would be adequate for 
considerable progress.  The data presented in this paper furnish indications 
of preliminary procedures that may advantageously be carried out for this 
purpose. 
One of the chief significant features of the agent is its selective attack on 
nerve cells, namely, the Purkinje cells  of the cerebellum.  This action is 
similar to that produced by the virus of louping ill.  It would be of great 
interest to discover the relation between a virus and a normal body protein, 
both producing an identical effect.  The other factors of this relationship 
are discussed elsewhere (16). 
SUMMARY 
The nature of the encephalopathic agent present in monkey bone marrow 
has been investigated.  It is readily soluble at a pH of 7.4, as well as at the 
low pH of 2.0 and 3.0.  The point of minimal solubility is pH 4.2.  Heat 
inactivation is produced by a temperature of 75°C., acting for 15 minutes. 
The agent is digested by pepsin.  It exhibits a slight degree of sedimenta- 
tion  with  the  air-driven  centrifuge.  It  is  non-dialyzable.  It  is  pre- 
cipitated from solution (pH  7.4)  by ammonium sulfate,  over a  range of 
0.4 to 0.8 saturation.  These findings all suggest that the agent is a protein. 
No immunological reactions could be elicited. 
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EXPLANATION OF PLATE 29 
FxG. I. A  normal  cerebellum,  showing  the  even  distribution  of  Purkinje  cells. 
×  35.3. 
FIG. 2.  Damage to cerebellum from intracerebral injection of monkey bone marrow 
extract.  The Purkinje cells have almost entirely disappeared and have been replaced 
by a vigorous glial reaction.  In the areas indicated by arrows, a few Purkinje ceils still 
persist intact.  This is an example of a q- + q- +  or maximal reaction.  X  35.3. THE JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL.  7i  PLATE 29 
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(King: Encephalopathic agent in primate bone marrow) 